n South African Pharmaceutical and Cosmetic Review - New manufacturing plant boosts the fight against HIV and AIDS : pharmaceutical focus

Volume 37, Issue 11
  • ISSN : 0257-2028



In September this year, Cipla Medpro, the fourth-largest pharmaceutical company in SA, opened a new manufacturing facility. Situated in KwaZulu-Natal, this R329 million plant is approved for multi-product manufacture by the Medicines Control Council and offers granule, tablet, capsule and effervescent formulation capabilities, as well as blister, strip, container and bottle packaging. The facility will also undertake the process to achieve FDA and World Health Organization certification.

Loading full text...

Full text loading...


Article metrics loading...


This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error